Union européenne - maltais - EMA (European Medicines Agency)

ucb pharma sa - lacosamide - epilessija - anti-epilettiċi, - vimpat huwa indikat bħala monoterapija u terapija aġġuntiva fit-trattament ta 'attakki li jibdew parzjalment bi jew mingħajr ġeneralizzazzjoni sekondarja f'adulti, adoloxxenti u tfal minn 4 snin b'epilessija.

Union européenne - maltais - EMA (European Medicines Agency)

bayer ag - telmisartan - pressjoni għolja - aġenti li jaġixxu fuq is-sistema renin-angiotensin - hypertensiontreatment ta'l-ipertensjoni essenzjali fl-adulti. kardjovaskulari preventionreduction tal-morbidità kardjovaskulari f'pazjenti bi: - manifest aterotrombotiċi mard kardjovaskulari (passat ta ' mard koronarju tal-qalb, puplesija, jew mard arterjali periferali) jew;dijabete tat-tip 2 mellitus dokumentata-mira-ħsara fl-organi.

Union européenne - maltais - EMA (European Medicines Agency)

bayer ag - telmisartan - pressjoni għolja - aġenti li jaġixxu fuq is-sistema renin-angiotensin - hypertensiontreatment ta'l-ipertensjoni essenzjali fl-adulti. kardjovaskulari preventionreduction tal-morbidità kardjovaskulari f'pazjenti bi: - manifest aterotrombotiċi mard kardjovaskulari (passat ta ' mard koronarju tal-qalb, puplesija, jew mard arterjali periferali) jew;dijabete tat-tip 2 mellitus dokumentata-mira-ħsara fl-organi.

Union européenne - maltais - EMA (European Medicines Agency)

hexal ag - epoetin alfa - anemia; kidney failure, chronic; cancer - preparazzjonijiet antianemiċi - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. , it-trattament ta 'anemija u tnaqqis tal-ħtiġijiet ta' trasfużjoni f'pazjenti adulti li qed jirċievu kimoterapija għal tumuri solidi, limfoma malinn jew myeloma multipla, u f'riskju ta ' trasfużjoni kif evalwat mill-pazjent ġenerali tal-istatus (e. l-istat kardjovaskulari pre-eżistenti ta ' l-anemija fil-bidu tal-kimoterapija).

Union européenne - maltais - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - infezzjonijiet taċ-ċitomegalovirus - antivirali għal użu sistemiku - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). għandha tingħata kunsiderazzjoni għall-gwida uffiċjali dwar l-użu adattat ta ' aġenti antivirali.

Union européenne - maltais - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - umeclidinium bromide, vilanterol - mard tal-pulmun, obstructive kronika - mediċini għall-imblokkar tal-passaġġ tan-nifs mard, - laventair ellipta huwa indikat bħala l-manutenzjoni bronkodilatur-kura biex ittaffi s-sintomi fil-pazjenti adulti bil-marda pulmonari ostruttiva kronika (copd).

Union européenne - maltais - EMA (European Medicines Agency)

gilead sciences ireland uc - emtricitabine, tenofovir alafenamide - infezzjonijiet ta 'hiv - antivirali għal użu sistemiku - descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (hiv-1).

Union européenne - maltais - EMA (European Medicines Agency)

gilead sciences ireland uc - elvitegravir, kobikistat, emtricitabine, tenofovir alafenamide - infezzjonijiet ta 'hiv - antivirali għal użu sistemiku - genvoya huwa indikat għall-kura ta ' l-adulti u l-adolexxenti (korp età 12-il sena u aktar antiki mal-piż mill-anqas 35 kg) infettati bil-virus ta ' immunodefiċjenza umani 1 (hiv 1) mingħajr ebda mutazzjonijiet magħrufa assoċjati mal-reżistenza għall-klassi ta ' inibitur ta ' integrase, emtricitabine jew tenofovir.

Union européenne - maltais - EMA (European Medicines Agency)

gilead sciences ireland uc - tenofovir alafenamide fumarate - epatite b - antivirali għal użu sistemiku - vemlidy is indicated for the treatment of chronic hepatitis b (chb) in adults and paediatric patients 6 years of age and older weighing at least 25 kg (see section 5.

Union européenne - maltais - EMA (European Medicines Agency)

gilead sciences ireland uc - bictegravir, emtricitabine, tenofovir alafenamide, fumarate - infezzjonijiet ta 'hiv - antivirali għal użu sistemiku - biktarvy is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir. (ara sezzjoni 5.